• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新千年伊始瑞典癌症患者的生存率——基于时期分析的预测

Cancer patient survival in Sweden at the beginning of the third millennium--predictions using period analysis.

作者信息

Talbäck Mats, Rosén Måns, Stenbeck Magnus, Dickman Paul W

机构信息

Centre for Epidemiology, The National Board of Health and Welfare, Stockholm, Sweden.

出版信息

Cancer Causes Control. 2004 Nov;15(9):967-76. doi: 10.1007/s10522-004-2475-1.

DOI:10.1007/s10522-004-2475-1
PMID:15577299
Abstract

Estimates of cancer patient survival made using traditional, cohort-based, methods can be heavily influenced by the survival experience of patients diagnosed many years in the past and may not be particularly relevant to recently diagnosed patients. Period-based survival analysis has been shown to provide better predictions of survival for recently diagnosed patients and earlier detection of temporal trends in patient survival than cohort analysis. We aim to provide predictions of the long-term survival of recently diagnosed cancer patients using period analysis. The period estimates are compared with the latest available cohort-based estimates. Our results, based on period analysis for the years 2000-2002, suggest an improvement in survival for many forms of cancer during recent years. For all sites combined the 5-, 10-, 15-, and 20-year relative survival ratios were 62%, 53%, 48%, and 47% for males and 67%, 62%, 60%, and 59%, for females. These estimates were 3-14% units higher than those obtained using the latest available cohorts with the respective lengths of follow-up. The interval-specific relative survival stabilised for males at 97% after 8 years of follow-up and for females at 98% after 7 years for both period and cohort analyses.

摘要

使用传统的基于队列的方法对癌症患者生存率进行的估计,可能会受到多年前确诊患者生存经验的严重影响,而且可能与近期确诊的患者并无特别关联。与队列分析相比,基于时期的生存分析已被证明能为近期确诊的患者提供更好的生存预测,并能更早地发现患者生存的时间趋势。我们旨在通过时期分析对近期确诊的癌症患者的长期生存情况进行预测。将时期估计值与最新可得的基于队列的估计值进行比较。我们基于2000 - 2002年的时期分析得出的结果表明,近年来多种癌症的生存率有所提高。所有部位综合起来,男性的5年、10年、15年和20年相对生存率分别为62%、53%、48%和47%,女性分别为67%、62%、60%和59%。这些估计值比使用最新可得队列且具有相应随访时长所获得的估计值高3 - 14个百分点。对于时期分析和队列分析,男性在随访8年后特定区间相对生存率稳定在97%,女性在随访7年后稳定在98%。

相似文献

1
Cancer patient survival in Sweden at the beginning of the third millennium--predictions using period analysis.新千年伊始瑞典癌症患者的生存率——基于时期分析的预测
Cancer Causes Control. 2004 Nov;15(9):967-76. doi: 10.1007/s10522-004-2475-1.
2
Predicting the survival of cancer patients recently diagnosed in Sweden and an evaluation of predictions published in 2004.预测瑞典近期确诊癌症患者的生存率及对 2004 年发表的预测结果的评估。
Acta Oncol. 2012 Jan;51(1):17-27. doi: 10.3109/0284186X.2011.626444. Epub 2011 Oct 24.
3
Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.北欧国家 1964-2003 年间诊断为癌症的患者的生存趋势,随访至 2006 年底。材料和方法。
Acta Oncol. 2010 Jun;49(5):545-60. doi: 10.3109/02841861003739322.
4
Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.北欧国家 1964-2003 年间男性生殖器癌症患者的生存趋势,随访至 2006 年底。
Acta Oncol. 2010 Jun;49(5):644-54. doi: 10.3109/02841860903575315.
5
Long-term survival expectations of cancer patients in Europe in 2000-2002.2000 - 2002年欧洲癌症患者的长期生存预期
Eur J Cancer. 2009 Apr;45(6):1028-41. doi: 10.1016/j.ejca.2008.11.005. Epub 2008 Dec 16.
6
Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data.癌症患者的最新长期生存率:基于瑞典癌症登记数据的时期分析评估
Eur J Cancer. 2004 Jun;40(9):1361-72. doi: 10.1016/j.ejca.2004.02.004.
7
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.2001-2004 年英格兰、挪威和瑞典的肺癌生存率的国家比较:随访早期就出现差异。
Thorax. 2010 May;65(5):436-41. doi: 10.1136/thx.2009.124222.
8
An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry.利用加拿大癌症登记处的数据对时期生存分析进行实证评估。
Ann Epidemiol. 2006 Mar;16(3):191-6. doi: 10.1016/j.annepidem.2005.02.017. Epub 2005 Aug 15.
9
Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.相对生存率分析中预期生存概率的估计——探讨将癌症患者死亡率纳入计算的影响。
Eur J Cancer. 2011 Nov;47(17):2626-32. doi: 10.1016/j.ejca.2011.08.010. Epub 2011 Sep 15.
10
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases.癌症登记处中事件病例记录延迟情况下最新长期生存率的混合分析。
Eur J Cancer. 2004 Nov;40(16):2494-501. doi: 10.1016/j.ejca.2004.07.022.

引用本文的文献

1
Enhancing TNM Stage Completeness Using the SEER Summary Stage: A Nationwide Study From Korea.利用监测、流行病学和最终结果(SEER)总结分期提高TNM分期的完整性:一项来自韩国的全国性研究
J Prev Med Public Health. 2025 Jul;58(4):415-421. doi: 10.3961/jpmph.25.099. Epub 2025 Apr 23.
2
Using temporal recalibration to improve the calibration of risk prediction models in competing risk settings when there are trends in survival over time.利用时变校准来改进风险预测模型在竞争风险环境中的校准,当存在随时间变化的生存趋势时。
Stat Med. 2023 Nov 30;42(27):5007-5024. doi: 10.1002/sim.9898. Epub 2023 Sep 13.
3
Temporal recalibration for improving prognostic model development and risk predictions in settings where survival is improving over time.
用于在生存随时间改善的情况下改进预后模型开发和风险预测的时间重新校准。
Int J Epidemiol. 2020 Aug 1;49(4):1316-1325. doi: 10.1093/ije/dyaa030.
4
Dysphagia predict the response to second cycle neoadjuvant chemotherapy in first cycle no response esophageal carcinoma.吞咽困难可预测首程新辅助化疗无反应的食管癌患者对第二程新辅助化疗的反应。
J Thorac Dis. 2019 Oct;11(10):4135-4143. doi: 10.21037/jtd.2019.10.02.
5
Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis.无法手术的食管癌中食管金属支架置入和联合治疗的作用:系统评价和荟萃分析。
Dig Dis Sci. 2018 Apr;63(4):1025-1034. doi: 10.1007/s10620-018-4957-z. Epub 2018 Feb 8.
6
The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors.术前症状对小肠神经内分泌肿瘤患者死亡的影响
Ann Surg Oncol. 2017 May;24(5):1214-1220. doi: 10.1245/s10434-016-5703-4. Epub 2016 Nov 30.
7
A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer.一项比较序贯放化疗与同步放化疗治疗不可切除局部晚期食管癌的随机研究。
Indian J Med Paediatr Oncol. 2014 Jan;35(1):54-9. doi: 10.4103/0971-5851.133722.
8
Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.多排螺旋 CT 测量可切除食管鳞癌肿瘤大小对预测区域淋巴结转移和 N 分期的价值。
Eur Radiol. 2012 Nov;22(11):2487-93. doi: 10.1007/s00330-012-2512-4. Epub 2012 Jun 1.
9
The aging population in Sweden: can declining incidence rates in MI, stroke and cancer counterbalance the future demographic challenges?瑞典人口老龄化:MI、中风和癌症发病率下降能否应对未来的人口挑战?
Eur J Epidemiol. 2012 Feb;27(2):139-45. doi: 10.1007/s10654-012-9653-2. Epub 2012 Feb 18.
10
Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.三级转诊中心治疗小肠神经内分泌肿瘤的长期手术结果。
World J Surg. 2012 Jun;36(6):1419-31. doi: 10.1007/s00268-011-1296-z.